SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

SUTRO BIOPHARMA Q3 REVENUE USD 9.098 MILLION VS. IBES ESTIMATE USD 10.3 MILLION

STRO

Related stories